Actimed Therapeutics
PrivateLast Round
Series A
Aug 22, 2023
Total Funding Raised
$35.51M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Actimed Therapeutics is a clinical-stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Actimed Therapeutics Comparables
Compare Actimed Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Endevica Bio | 80% | |
| SynDevRx | 79% | |
| Pephexia Therapeutics | 79% | |
Actimed Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 22, 2023 | ||||
| Series A | Jun 26, 2023 | ||||
| Seed | Jan 4, 2023 | ||||
| Seed | Jun 10, 2021 | ||||
| Corporate Funding | Apr 13, 2021 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 261% MoM, reaching 1.4K.
- Dec 9, 2025
Presenting new clinical pipeline data at Sarcopenia conference.
Actimed Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Actimed Therapeutics's valuation, stock price, and market status.